vs

Side-by-side financial comparison of Richmond Mutual Bancorporation, Inc. (RMBI) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.

Richmond Mutual Bancorporation, Inc. is the larger business by last-quarter revenue ($13.1M vs $7.1M, roughly 1.8× TECHPRECISION CORP). Richmond Mutual Bancorporation, Inc. runs the higher net margin — 26.1% vs -20.8%, a 46.9% gap on every dollar of revenue. On growth, Richmond Mutual Bancorporation, Inc. posted the faster year-over-year revenue change (18.1% vs -6.9%). Richmond Mutual Bancorporation, Inc. produced more free cash flow last quarter ($14.6M vs $-827.0K). Over the past eight quarters, Richmond Mutual Bancorporation, Inc.'s revenue compounded faster (9.1% CAGR vs -9.2%).

Richmond Mutual Bancorporation, Inc. is a U.S.-based bank holding company operating primarily in Indiana. It offers a full range of personal and commercial banking solutions including deposit accounts, mortgage loans, small business lending, and wealth management services, serving local retail consumers and small-to-medium enterprise clients via its regional branch network.

TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.

RMBI vs TPCS — Head-to-Head

Bigger by revenue
RMBI
RMBI
1.8× larger
RMBI
$13.1M
$7.1M
TPCS
Growing faster (revenue YoY)
RMBI
RMBI
+25.0% gap
RMBI
18.1%
-6.9%
TPCS
Higher net margin
RMBI
RMBI
46.9% more per $
RMBI
26.1%
-20.8%
TPCS
More free cash flow
RMBI
RMBI
$15.4M more FCF
RMBI
$14.6M
$-827.0K
TPCS
Faster 2-yr revenue CAGR
RMBI
RMBI
Annualised
RMBI
9.1%
-9.2%
TPCS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
RMBI
RMBI
TPCS
TPCS
Revenue
$13.1M
$7.1M
Net Profit
$3.4M
$-1.5M
Gross Margin
5.4%
Operating Margin
-19.1%
Net Margin
26.1%
-20.8%
Revenue YoY
18.1%
-6.9%
Net Profit YoY
37.7%
-84.4%
EPS (diluted)
$0.35
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMBI
RMBI
TPCS
TPCS
Q4 25
$13.1M
$7.1M
Q3 25
$12.6M
$9.1M
Q2 25
$11.8M
$7.4M
Q1 25
$11.4M
$9.5M
Q4 24
$11.1M
$7.6M
Q3 24
$10.8M
$8.9M
Q2 24
$10.7M
$8.0M
Q1 24
$11.0M
$8.6M
Net Profit
RMBI
RMBI
TPCS
TPCS
Q4 25
$3.4M
$-1.5M
Q3 25
$3.6M
$825.0K
Q2 25
$2.6M
$-597.0K
Q1 25
$2.0M
$112.0K
Q4 24
$2.5M
$-799.0K
Q3 24
$2.5M
$-601.0K
Q2 24
$2.1M
$-1.5M
Q1 24
$2.4M
$-5.1M
Gross Margin
RMBI
RMBI
TPCS
TPCS
Q4 25
5.4%
Q3 25
27.1%
Q2 25
14.0%
Q1 25
22.0%
Q4 24
13.0%
Q3 24
11.3%
Q2 24
3.0%
Q1 24
14.3%
Operating Margin
RMBI
RMBI
TPCS
TPCS
Q4 25
-19.1%
Q3 25
10.4%
Q2 25
-6.3%
Q1 25
3.9%
Q4 24
-9.1%
Q3 24
-5.5%
Q2 24
-16.8%
Q1 24
-28.6%
Net Margin
RMBI
RMBI
TPCS
TPCS
Q4 25
26.1%
-20.8%
Q3 25
28.6%
9.1%
Q2 25
22.0%
-8.1%
Q1 25
17.2%
1.2%
Q4 24
22.4%
-10.5%
Q3 24
23.0%
-6.7%
Q2 24
19.3%
-18.3%
Q1 24
21.6%
-59.5%
EPS (diluted)
RMBI
RMBI
TPCS
TPCS
Q4 25
$0.35
$-0.15
Q3 25
$0.36
$0.08
Q2 25
$0.26
$-0.06
Q1 25
$0.20
$0.01
Q4 24
$0.25
$-0.08
Q3 24
$0.24
$-0.06
Q2 24
$0.20
$-0.16
Q1 24
$0.23
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMBI
RMBI
TPCS
TPCS
Cash + ST InvestmentsLiquidity on hand
$33.1M
$50.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$145.8M
$8.0M
Total Assets
$1.5B
$32.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMBI
RMBI
TPCS
TPCS
Q4 25
$33.1M
$50.0K
Q3 25
$34.3M
$220.0K
Q2 25
$27.2M
$143.0K
Q1 25
$27.0M
$195.0K
Q4 24
$21.8M
$165.0K
Q3 24
$19.6M
$132.0K
Q2 24
$19.0M
$44.8K
Q1 24
$20.3M
$138.0K
Total Debt
RMBI
RMBI
TPCS
TPCS
Q4 25
Q3 25
Q2 25
Q1 25
$3.0K
Q4 24
$19.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RMBI
RMBI
TPCS
TPCS
Q4 25
$145.8M
$8.0M
Q3 25
$140.0M
$9.1M
Q2 25
$132.3M
$8.2M
Q1 25
$130.9M
$8.7M
Q4 24
$132.9M
$8.1M
Q3 24
$140.0M
$8.9M
Q2 24
$131.1M
$7.9M
Q1 24
$132.4M
$7.8M
Total Assets
RMBI
RMBI
TPCS
TPCS
Q4 25
$1.5B
$32.8M
Q3 25
$1.5B
$33.8M
Q2 25
$1.5B
$32.1M
Q1 25
$1.5B
$33.5M
Q4 24
$1.5B
$32.2M
Q3 24
$1.5B
$35.0M
Q2 24
$1.5B
$35.7M
Q1 24
$1.5B
$34.7M
Debt / Equity
RMBI
RMBI
TPCS
TPCS
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMBI
RMBI
TPCS
TPCS
Operating Cash FlowLast quarter
$16.0M
$183.0K
Free Cash FlowOCF − Capex
$14.6M
$-827.0K
FCF MarginFCF / Revenue
111.9%
-11.7%
Capex IntensityCapex / Revenue
10.4%
14.2%
Cash ConversionOCF / Net Profit
4.68×
TTM Free Cash FlowTrailing 4 quarters
$26.7M
$-4.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMBI
RMBI
TPCS
TPCS
Q4 25
$16.0M
$183.0K
Q3 25
$6.3M
$-1.1M
Q2 25
$4.8M
$646.0K
Q1 25
$2.2M
$396.0K
Q4 24
$14.8M
$-570.0K
Q3 24
$2.9M
$-532.0K
Q2 24
$2.9M
$107.0K
Q1 24
$2.2M
$-452.0K
Free Cash Flow
RMBI
RMBI
TPCS
TPCS
Q4 25
$14.6M
$-827.0K
Q3 25
$5.8M
$-2.1M
Q2 25
$4.2M
$-604.0K
Q1 25
$2.1M
$-930.0K
Q4 24
$14.3M
$-1.7M
Q3 24
$2.8M
$-2.0M
Q2 24
$2.8M
$-94.0K
Q1 24
$2.0M
$-900.0K
FCF Margin
RMBI
RMBI
TPCS
TPCS
Q4 25
111.9%
-11.7%
Q3 25
46.2%
-22.9%
Q2 25
35.6%
-8.2%
Q1 25
18.4%
-9.8%
Q4 24
129.3%
-22.9%
Q3 24
25.7%
-21.8%
Q2 24
26.2%
-1.2%
Q1 24
18.7%
-10.5%
Capex Intensity
RMBI
RMBI
TPCS
TPCS
Q4 25
10.4%
14.2%
Q3 25
3.7%
11.0%
Q2 25
5.3%
16.9%
Q1 25
0.7%
14.0%
Q4 24
4.2%
15.4%
Q3 24
1.1%
15.9%
Q2 24
1.1%
2.5%
Q1 24
1.1%
5.2%
Cash Conversion
RMBI
RMBI
TPCS
TPCS
Q4 25
4.68×
Q3 25
1.75×
-1.31×
Q2 25
1.86×
Q1 25
1.11×
3.54×
Q4 24
5.96×
Q3 24
1.17×
Q2 24
1.42×
Q1 24
0.91×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMBI
RMBI

Segment breakdown not available.

TPCS
TPCS

Defense$6.7M94%
Other$410.0K6%

Related Comparisons